Table 2.
Drug | Target | Imaging readout | Effect | Reference |
---|---|---|---|---|
Multi-nutrient diet | Broad spectrum | [18F]DPA-714, DTI, rsfMRI | Inflammation ↓, DTI, rsfMRI ↑, functional outcome ↑ | 54 |
Minocycline | Broad spectrum | [18F]DPA-714 and [18F]PBR06 PET, MRI | Inflammation ↓, functional outcome ↑ | 69, 76 |
sulfasalazine and S-4-CPG | inhibition of system xc | [18F]DPA-714, [18F]FSPG | Inflammation ↓ | 72 |
DhβE | α4β2 antagonist | [11C]PK11195 and 2[18F]-fluoro-A85380 | Inflammation ↑ | 77 |
AMD3100 | CXCR4 antagonist | [18F]DPA-714 | Inflammation ↓ | 70 |